Related Experiment Videos
Heterogeneity in hormone receptor status in primary and metastatic breast cancer
Seminars in Oncology
|September 1, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.
Breast cancer research and treatment·2017
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.
Breast cancer research and treatment·2012
Systemic mirnas as potential biomarkers for malignancy.
International journal of cancer·2012
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.
Molecular endocrinology (Baltimore, Md.)·2011
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.
Breast cancer research and treatment·2010
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.
Seminars in oncology·2026
NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.
Seminars in oncology·2026
Dual alexithymia: A relational framework for clinical communication in oncology.
Seminars in oncology·2026
SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.
Seminars in oncology·2026
The role of fumarate and itaconate in tumor microenvironment.
Seminars in oncology·2026
Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.
Seminars in oncology·2026